Menu
GeneBe

TMEM231

transmembrane protein 231, the group of MKS complex

Basic information

Region (hg38): 16:75536740-75556289

Links

ENSG00000205084NCBI:79583OMIM:614949HGNC:37234Uniprot:Q9H6L2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Meckel syndrome (Supportive), mode of inheritance: AR
  • Joubert syndrome with oculorenal defect (Supportive), mode of inheritance: AR
  • orofaciodigital syndrome III (Supportive), mode of inheritance: AR
  • Joubert syndrome 20 (Definitive), mode of inheritance: AR
  • Joubert syndrome 20 (Strong), mode of inheritance: AR
  • ciliopathy (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Joubert syndrome 20; Meckel syndrome 11ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingGastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal23012439; 23349226
Conditions may involve multi-systemic manifestations, including sequelae affecting the renal and hepatic systems, and surveillance and avoidance of certain medications (eg, nephrotoxic agents) may be beneficial;

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TMEM231 gene.

  • Joubert syndrome 20;Meckel syndrome, type 11 (172 variants)
  • Meckel syndrome, type 11;Joubert syndrome 20 (134 variants)
  • not provided (80 variants)
  • Inborn genetic diseases (36 variants)
  • not specified (28 variants)
  • Joubert syndrome 20 (10 variants)
  • Joubert syndrome and related disorders (8 variants)
  • Meckel syndrome, type 11 (7 variants)
  • Orofacial-digital syndrome III (1 variants)
  • Congenital anomaly of kidney and urinary tract (1 variants)
  • Ciliopathy (1 variants)
  • Normal pregnancy (1 variants)
  • Familial aplasia of the vermis (1 variants)
  • Meckel-Gruber syndrome (1 variants)
  • TMEM231-related condition (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TMEM231 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
67
clinvar
4
clinvar
75
missense
1
clinvar
4
clinvar
139
clinvar
12
clinvar
1
clinvar
157
nonsense
4
clinvar
2
clinvar
4
clinvar
10
start loss
2
clinvar
1
clinvar
3
frameshift
5
clinvar
1
clinvar
6
inframe indel
0
splice donor/acceptor (+/-2bp)
2
clinvar
2
clinvar
1
clinvar
5
splice region
2
3
8
5
2
20
non coding
1
clinvar
2
clinvar
19
clinvar
33
clinvar
23
clinvar
78
Total 13 11 169 113 28

Highest pathogenic variant AF is 0.0000197

Variants in TMEM231

This is a list of pathogenic ClinVar variants found in the TMEM231 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-75537350-G-GCCTCATCTGACTTAAGCCGAAACTGTACTAATCATTTGGCAAAATCAGGAGTCTTTCTGCCTCCAAATATTCAGTAATAACATCAAACCTTAACTTAGCTATGGGTCGGAGCTGAGTTAATAAAATCCTCTATATTTCTTTTTTTTTTTTTTTTTGAGACGGAGTCTAGCTCTGTTGCCAGGCTGGAGTGCAGTGGCGCAATCTCGGCTCACTGCAACCTCCGCCTCCAGGGTTCAAGCGATTCTCCTGCCTCAGCCTACTAAATAGTTGGGATGACAGGCACGTGTCGCCACACCCAGCCAATTTTTGTATTTTTAGTGGAGATGGGGTTTCACCATGTTGGCCAGGATGGTCTCGATCTCCTGACCTTGTGATTCACCCACCTCGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCGCTCCCGGCCTCTTGCTTTTTATTTACCTCTTGCAGCTATGCTGTGATTCAGAGTCAGAAACTATCAACATCTGGTCTGTAAATAATTTCATATTCACCAGACACAGTCATAATTATCCAACACGTAGATTTCACATGGCATGTGAATCCCACTGAAAACTCATCTACCTGGGGAAGAACTAGGGGACTTTCACCAAAGACCTCATGGAAGTTCCAAGGTCGTTAGGCAGAGCCTTGTAAAGCATGGCTGTAGATGAGTAATAAAGACAGGTGTGTGCAACCTCTGCCCTCCCTATTCTTTGCCATTCCAAACCCTTTCCCTCGAAAAAGGTACATGTGATCTTCCATTTTGACTTTTTTATTTATTTATTTATTTATTTTAACAGATAGGGTCTCACTCTGTCACCCAGGCTACAGTACAGTGGTGCAATCATAGCACACTGCAGCCTCAAGCTCCTGGGCTCAAGTGATCCTCCCACCTTGGCCTCCCAAAGTGTTGAGATTACAGGAATGAACCACCATGCTCGGCCTCATTTTGAACATTTTAATTAGAAAGTTACAAAACATCATGGGTTCTTTATACAAGATTTGCATTAGAATAATTTAATAAAATGCAAACCAATGTTTATACGTATCTTGTCATCTTTCCATATCTCATTGCCTTATGTGAATTTAAACAAGAAACTATTTTTCGTTTAGATCTTAAGAAAAAAATTTAGGCATATAAAACAGCCTGAATATTAAAAAAAGACAAGGGGGTCAGTGTTAGGGAATTCCTCTGCTTGAATACTTCAAAATAGCTTTGTTTCCAAAACTGTTTTAGTAAGCCTAAAGGAGCACTAAAAACGACAACTGATCTCCAAAGTAAACTGAGGCACACACTGAGGGGTGTGTTTCTGGGTGGGCATGAAGCATGGATCACCGGGGCCATGTCCTTCCAGTGGCAATGACCTGCTTGGGATCAGGAAGCAGCTCCATGTGTTCTTGGAGGAGACTGCCCACATCCTCAGGAGGTGAATGGGCTGAACAAGCCATCTTCCGTGTGCAGAGGCCCCTTCCAGCCATCTCTGCTCCTGCAGACACTTGCTTAGCCACGAGGGTAATCCACTGGACTGCTTGGTATTCTGCTAGTGGCCAGGCTGGACTGGCCTGCCCAGGCCAGCATCCTCTTTACACTCTTACTGCTTCTTGTGTCCTTCCCAAAGCTGCCCGCCCCACTCTGATGGGCACCCTGTTCCTTAGTCAAGGGAAACGCCAGCCGCTGGGCTTCCCGCTAGCCTTCCAAATAAACTTGTGGTTGTCAGGCAGCGGGAGCCAATCCCAACACCAACCCCTGTCGCCCCTGTCCTTTGCAGGAAGGGGGAGGGCTGTCAAGGAGGAGGAGGGCCAAGTGCCCAGGCTGTTGGGTGAGGGCCAGAAAGAACCTGTTGTGACAATGCTTTCTTCCCCCAGTGCTGCTGAGGGGGCTGAGAATGAAACAGCCCCTCTGACTTCAGCCTGCCATCCAGGGGCACAGACAGAGGGAAAAATAGGGCAAAGAGCCCAGTCACAGTACGGCAAAGATCCAGGGCTGCTCAGCTGAGCTGATGACAGATGACTGACTGTTGGGCTGGGGCAGGTGGACGGTCCAAGTGTCCTTCAGCGGCCCTCCCTGATTGCCTGTGCTAATGCGGCCCTTGCCCTTGGGCCCTGCCCCTCCAGGTCTCCAGTTAAAGGCCTCAGCTCTGGAAATCAAAGCTGTGAATGGGAAATGGAGAAGCCCAGGGGTGCAAAGTGCTAGTGATTGGCATGTTTGTCACAAGAGAGCCCTGAAAAGAGTAAGAGTGGCTCACAACAGAAGGTAGAAATGCACAGTGTGTTCCTCAGTTCAACAGAGGAAAAGTCTCTGCTTGACCAGAGATGGGACTCTTTCCAAGATGTCTGAACTGACTGCAATTTTCTCCTGAAATTCAACGCTAAGGCAAAGAAGGAAAACCCAAAAAGCTAATTATAGCCTCCAGGAACTCTCAGACCTTTCCACAAACTAGTCCCTGACAATTCTGCAGGAGCTCTGAAGATACGGAACTGTGTAGAGCAAAACCGGAAAGAACCGTTGTCTCTGAGGGAAAAGCACACAAGCCCGCAGGTGTCCGCTGGGCTCTTTCAAAAGGTCCTAAGATGTTCCCAGAAGATGACAATGAGGCAGCCACGGTCCTGCTGAGTCTTCAGAAATGGCCTTTCTAGGATAAGTGCTCCTTACACAAGTCTCCCCGGGGCGTCACTGTCACAGGAATGGTGGTCACCACCTGATTCTGAAACACGAAGATCTTGATTCTTTCAAACACCCAGAGGAAGATAAGCAGGATGCTGACATACTGCACCCAGGCGAACTTTACCATCTCCCAGAATCCTGGCTGATAAGTATGGACAGTTAAGGAGTGAAGGGCCACATGGTGTTAAGTATGAAGAGAAAATCCAAGATGGAATTGGCTGTGGCAGAGGTATCTCGAAAGGAGGCAGGACCTCTGTCATGTACACACCCAGATGGAAGCTGACCTGAACTTGGCCAAATGGTAAAACCAGCCACATTTGATTTGAGCTATTTATATACCAAGCCTGATGACCAACCTCCTAAACAGACAACTATGCCAAACTAGATTGATCATGGACTAGAGATATCCTGAGCTGTTAACCAGCCATCCATCCATCTTCTAAAATCTTCCAGTTGTGTAAACTTGGAACACCCTTAGCCCCTGCCTAATTGCACCTGTACGGAACACAATTTAGCTGCTTCCTAGGTTTGTGTCTCTGGAATTGTAATTCCTAAGACCCCAGTTAAAATGCCTTCTCTTTTGTTTGCTTCTCTGCAGTGTTGGTGTTGGTTTCATTTTCCATTAGTCGACCTAAGTCAAAATTAAACCAAAGTTTAGGTCAGACAGGGACTGGCAAGAATGTTTCACATAACCTTAGCATAAAAGGGATATCATATGATTATTAAGACATAAATATGGATGATTCTTACCTAGAAGAATTGCTTGGAAACAAATAGGACCAAGACATGAATTATTTGTTCCTATATGAATAGCAGACATACAGTCATTTTCTGAGACATGTAGCCTAAGATGTCAAAGACGCAGCCATTTTTATGAGGCTATAACCCTGTCATGATTTCCAAGAGAAAACCTCCCACGTCTGTTACTACTTGAGACAACTAAGGAATCATTCCTCTTTGAAAACTGAGCTACCATTGATTTTTTTTAAATTGTTGTTTGCTTTAAGAGGCAGGGTCTCACTCTGTCACCGAGGCTGGAGTACAGTGGCACAATCATCGCTCACTGCAAGCTTGAATTCCTGGACTCAAGCAATCCTCCTGCCTCGGCATCCCAAGTAACTGGGACTACACATGTACGCCACTATGCCTGGCTAATTTTTTTTTTTTTTTTTTTGGTAGAGACAGGGACTCACTATCTTGGCCAGGCTGGTTGTGAACTCCTGGGTTCAAATGATCCTCCCACCTTGGCCTCCCAAAGTGCTGAAATTATAGGCAGGAGCCACCACATCCAGCCTTAACATGGACTCTTTAACAGAAAGGATATGAAATGACTTCCACAGGGTATCGGATGATAGCATTAATCACAAATGGAGCATCTGCGGCCCTGCCCACCAGCCAGATGGGGTTGGGATCATTCAGGACGGTGGTAACTGCAATGCAATCATTAACCATTAACCACGATGGCTGTTTGACTCTGGCAGTTGAAGGCTATAAAGATTATTTGATACCTGGAAATTATCCTGTGCTTCAGAACTGAAAGAAATCATTCGGAAGGAAAGAGAAATTGCATGTGCAAAGCTGATCACACATTATTTGTTAAAATAATAGTCAAAATACTTTTGTTAAAATACATAAAAAACTTGGAAAGAGTTTCTTCTACATGTGCTGAATGGCTAACTGAAGGAATACTATACTGCCACTAAAAGTAGTATCACAGCTTTGTAGCTGTGTGGGGAAGTATTTATATTCCAAGTTTAAATAAATAAAAGTAACTTGGATCCCAATGTGTTTCTACACTACAATGGCTGTATAAAAAGATCTGCAGAAGGCTAAAGAATGAAAGGAATGAAAAAATAGTTGATTTGTAGGGCAATGTTTTCTACTTTTGTTTTAAAATTCCCTCTATTATTGCAATAATGCCACTAGTATATGCCATAAAATCAGTAAGCAATACTGGATTTGCAGTCATCCCCCTTGTGAGACGTCTGTGTATAGTCTCCATGATGTCTGCTTGCCAAGTAACACTGTAGATGCTTTTAGAGAAAACCTCAGCCACCGACCAGACAAACGTGCCGAGTCCACACATGCCATGGCCTAGAGCTCTGTAAGGAATAAGCACACTGTGCCTTCTGGCAGGAAACAGGGGCACTCCTGTTCTCCTGCTGGACTGCTAATGTGGGGAGAGTCACCCACGTTCTCTGTTTTTCTCTGAAAAGCATGAACAGCAATTTGTCTTTGGCATCTGTTATAGGTGTGGATAGGTGTGGTATGGGGAACAACTCAATTAGGCTTATATTTTTTAAAAGAGAAACCCACTAAGCCAGTGGTGGGATAATGATGGCATTTAACCATCACTAGCCTGCTGGACCATGGGATGCTGGAGGGGTGGGGGCGGTCCCAGGTCTGAAGATCAGGACGAAAAAGACAAATCCTGGACAGCATATTTGCTCCCATCGTTGAGCATTCACGGGTTTTGACATTTTCATCACAAGGGTTCCAGTTCTGCTTGTCTCTGTTGCCCCCACTAACCTTGAAAGTCCTGAGCAGCGGCTGAATGGGCTCTACCTGTGACTCACCGTTCCTCTCCTGGTAGGCAGCAACAATATGGGTGAGGTCGTAGTCATAGGCAAAGGGGCTGGTCCCGTTGATCACGGATATCTGGGACACGGGAGGAGGATGTGGTGTGAGCACCTGGGAGACTCCTCCCCTTTTCCTTCTACCCTTCTGCCCACCCAGGCTGGTCCCACAGAGCACCCTCTTGTTCTTGGTGGCCTACTGCAGTATCAATAATCTTTTCTTCAAAGATGAATAAAACAGGCTGCTGCCCACCCAGGCTGGTCCCACAGAGCACCCTCTTGTTCTTGGTGGCCTACTGCAGTATCAATAATCTTCTCTTCAAAGATGAATAAACTCTCTTGCAACAATTTAAGCCCATTTACTCTCAGTCTTTCTTTCTGTGGATGGAAATAAGGGGTCAGTGTCCATGTTTTACAGGTTTTAAAGCTATTTTTAAAATACCCCTCTTTATCTCAGCGGGAGAAAGAATTCCTTAAATTATTTTAACAGACCGTATTTTCGCCAGGTGTGGTGGCTCATGCCTACAATCCCAGTGACTTGGGAGGCTGAGGCAGGAGGACCACTTGAGGCCATGAGTTCAAGGCCGTAGTCAATGATGATCATGCCACTCACTACACTCCAGTTTAGGAAACAGAGAAAGACTTCATCTCTCAAAAAAAAATAAAAATAAAAAAAAATAAAAAGCCAGGCATGGAAGCTCACGCCTCTAATCCCAACACTTTGGGAAGCCCAGGCAGATGGATCACTTGAGACCAGGAGTTCGAGACCAGTCTGGCCAACATGGTGAAACCCCATCTCTACTACAAAGAAAACAAAAATTAGCCAGGCGTGGTGGCATATGGCTGTAATCCCAGCTATTCAGGAGGCTGAAATCAGAGGATCTCTTAAGCCTGGGAGACAGAGGTTGCAGTGAGCCGAGATCATGCCACTCCACTGTAGCCTGGGTGACAGAGCAAGACTCTGTCTCAAAAATAAAAATAAAATACAAATAAAAACCCCTACACAAAGACAAAAAAAAGAAACCATACTTCCAACTCCTTTGTCATTTTCTTGGTCTTTTCTGGGTGCTAAGTTCTTTATCACTTTTAAATATAGAGATATAGATAAAATGCAAACCATAAGCATATAATCCCTTAAAGGAGGAAATAATTGCTTGCTGTTAATGTAATCTGATATATAGACATTCAAACAAAAAGTGCCATATTCATTTCATATGTTGCAGCTTCCTATTCTTTACAACTTATATTGATTATAGTCAGAGCAACAGTAAAACCCACTATATATCTACAAGTCTGGGTTTATGGCTGTAATAACCGATAACATCCCTTTTTCATTTTCAGAAGTACCTCAGCTCAACTTCTATGGTCCCCATTGTGATAAAATAAAAGTGAGGAATGAGTGATTAGATGCATGAGTTCTGCACACAGACAGGCTCTGTTATCTTTCAAGATTTGAGCCTTTGGGAAAATTAATCACTTTAAGCCCCAGTTACGTCTTCTGCAAAATGAGTTCATTATTTAAACAAGTATCTCTGTGAGCTTACCATCTGCCAGGCAGTGTGCTAGGCACGGATGTGATAGTATTTGAGATGCCACTGCTGTCAAGGCTGAGGGAGACAGCAAATAAACACACAAACACATATCCTGAGTAGGCCAGGCGGCAGGAGGGAGAGTCTGGCTGAGGAATGGTGGAAGGAGGGGCTGCTACTGTAGAAGCAGGTCAGAGAAGGACTGGGCTTGGGGATATCTGAACAGGGACCTGAATGGCATGGTCCGATAAGCCACATGGATGCCTGGCAGAGGAAATGGCAAAAGCAAAAGCCCTGAGGTGGCAGCTGCTTCTTGGGTTTGAGGAACAGCAAAAAGGCCAGGGGGGCTGGAAGGGAGCAAGCGGGGGCAGTGATGGGACAAGTGGCTGGAGTGCGGGGAAAGGACAATGCAGGCAGCTCAGAGGTTGCCATGATGATTAAAGGAGATGATATAGGTAAACGCCTGCACTCAGGGGTGGCATATGTTATGAGTTCAGTAAACTATGGCTAGTAATATTTCTGAAATACTTTACATGAACATTTTACATCATCATTTTACAGTGTCCTTCGGAGTACATCCTGCGTGTGACCAAGCGTGTGTATGGAAGACACAATGTGTGTGTGTGCACCCACGTGGACCTAAAAGCAATAAGCAATTTAGTTCTTCGACAAACACAGATTTTGTTTCTCTTCCCTTCTAGGTGTAACTATGCGTGTACCTTCTCTGTAGTTTGAAAAAATTCATGGCAAGAATTCTACAGAGACCCTCTTTGGTGCCACCCACAAAGAAATGATATTTCTACTTTTCTTTTCTTTTTCTTTTTTTTTTTTTTTTTTTTTTTTGAGACAGAGTCTTGCTCTGTTGCCCAGGCTGGAGTGCAGTGGCGAGATCTCAGCTCACTGTAACCTCCACCTCCTGGGTTCAAGCAATTCTCCTGCCTCAGTCTCCCAAGTAGCTAGGATTACAGGCACGCACCACACGCCTGGCTAATTTTTTGTATTTTTAGTAGAGACAGGGTTTCACCAGGTTGGCCAGACTGGTTTCAAACTCCGGACCTCAAGTGATCCATCCGCACATCTCCGCCTCCCAAAGTGCTGGGATTACAGGTATGAGCCACTGCGCCTGGCCTGACATTTCTACTTTTCATTCCCCTCTTTAAAGAACTTAATGAACAGTAACACAGAGAAACAAAGGAGCTGGACAATGAGAAGCGCTCTTACGTTGTATCGGGCATCTAGGCCACCACAGCTCAGCGGCTGCTTCTGCTGCAGCCTCAGGTCTCCGTTCACGTATAACTGGGATCCCGGGACAGGAAAGGAGGACTGGAGAAACGCCATGCTCTGCATCACGAGGGTCGCCATCCTCTGAAATCATTAGAAGGACCAACAATACCAACCGCCATCAGATCTGAAGGGCTCTGGGTGCTAAGAGTCACCTGTCTTGGCTGAAACCTAAGAGGCCCTCACATACCTAGCGTAGCCATGCAGGAAACACTGCCTAGAACCTTCTGAGCTATTAATAGCCCATGTCAGTTAATATGACTAGTGAAAACCATTCCATTGGCCTAAGTTAAATCCCAAACTACATGGGGAAGAGGGCCCGCTAGAGTGCGGGTCTTCTAGAAATCAGAAGAAGGACTCTGGTCTACTAAAAAGACACAAGGGAGAGGACAGCCTCCCAGCGGACTGACTCACGTGTAATCGATAGGAGAAAGTCAGGATGAGCTGCACACCGAGAACGTGCTCCGTGGACTGCAGGGGAAGCTCCAGCTTAAAATGTAACATGTCCGTCTTCCCATCCTGGTTCCTGTCTTCTTCTCTAGTCTAGGAAACCCAAACAGGCCCAGCAGCCCTGGTCACTAATGAGTCTGGGAGGAATCCACATCACTTCTGTAAATACACAATGACCCACTGTCTTGCTGTACACAACAGGCATTATCTCCTCCACTAAAAGAGAAAAGCAGATAGATGTAAGTGCATTAATACTGGGGAGAGACACAAAGTGCATGGTCCCTGAACTTCATATCTGGGCCTTTCAAATGTTCACTGGCCAAAATAAATGGGCAATAACAAAAAACATCTGGATAGTATTTGTGCCTTTCAGTTGTCTCATGTGATCTTGCTTATTTTGCACTGATATTTTTTTCTTTTTTACAAATATGCCTGAATTTGTATGGAAATTTTAAGTAGCATGTCAGAATAGTCTTCTATGTCTCTAGAAGTCAACTTGTTAAAATAGAAAAACACCTAATCCTAATCATTATGCATTCCTCCAACAAACTCAAACTCAACAGAAAATCACCAAGCTCTATTTTTTTTTGTTTTTTTTTGAGCCGGGGTCTAACTCTATCGCCCAGGCTGGAGTGCAGTGACGCAATCACGGCTCACTACAACCTCCGCCTCCCAGGGTCAAGGAATTGTCCTGCCTCAGCCTCCTGAGGAGCTGGGATTACAAGTGCCCACCACCATGCCCAGCTAATTTTTTTATTTTTAGTAGAGACTGGGTCTCACCATGTTGGCCAGGCTGATCTTGAACTCCTGACCTCGGGTGATCCGCCCACCTCAGGCTCCCAAAGTGCTAGGATTATAGGCGTGAGCCACCGCACCCGGCCTTACCAAACTCTGTTTATAGATTCTGAAACCACGAGTGTCTTTGCTTCAGATTCTTGATGTTGGATCTTATCTCATCATTCGTGTGAGGACCTGAAAGCCTTGTGCATCTTTTAGTAGCAATCAATGAAATGAAAAAGGAAGCTATGTCAAATCAGCAAAGTATTAAAACCATATCTATTTGATAAATTACGGGCATGAAAGGAAAGAAGACAGAGGTCTGTAGAGGAAAAAAGACAAAATACAGCTTATGAAGCATATGTAGGCAGTGAAAAAAAACTGGTATCCACTCCTACCATCCACAGTCTTGCCAAACAGTGATGCTAAAATGATGATCAGGAAAGCAC Normal pregnancy not provided (-)157371
16-75539855-C-T Benign (Jun 14, 2018)1247731
16-75539856-G-A Benign (Jun 30, 2018)1296183
16-75539986-T-C not specified Benign (Jan 22, 2016)257328
16-75540001-A-C not specified Uncertain significance (May 26, 2022)1696163
16-75540002-A-G Meckel syndrome, type 11;Joubert syndrome 20 Likely benign (Nov 02, 2023)2925183
16-75540006-C-T Joubert syndrome 20;Meckel syndrome, type 11 Likely benign (Jan 27, 2022)2067472
16-75540013-C-A Inborn genetic diseases Uncertain significance (Oct 03, 2022)2315275
16-75540014-A-C Inborn genetic diseases Uncertain significance (Nov 15, 2021)2261486
16-75540015-C-T Joubert syndrome 20;Meckel syndrome, type 11 Likely benign (Jan 02, 2024)1157065
16-75540017-A-C Joubert syndrome 20;Meckel syndrome, type 11 • TMEM231-related disorder Likely benign (Jun 01, 2023)786834
16-75540017-AG-CT Joubert syndrome 20;Meckel syndrome, type 11 • not specified Conflicting classifications of pathogenicity (Jan 29, 2024)473321
16-75540018-G-A Meckel syndrome, type 11;Joubert syndrome 20 Likely benign (Jun 23, 2023)1920639
16-75540018-G-T Joubert syndrome 20;Meckel syndrome, type 11 Likely benign (Jun 01, 2023)786835
16-75540019-T-A Joubert syndrome 20;Meckel syndrome, type 11 Uncertain significance (Apr 11, 2022)2042387
16-75540023-C-A Meckel syndrome, type 11;Joubert syndrome 20 Uncertain significance (Nov 08, 2022)2130345
16-75540025-C-T Joubert syndrome 20;Meckel syndrome, type 11 Uncertain significance (May 21, 2021)1391864
16-75540026-G-A Meckel syndrome, type 11;Joubert syndrome 20 Uncertain significance (Jul 07, 2023)1399815
16-75540030-C-T Joubert syndrome 20;Meckel syndrome, type 11 Likely benign (Dec 26, 2023)1148277
16-75540036-T-G Likely benign (Jan 01, 2024)3026875
16-75540041-C-T Meckel syndrome, type 11;Joubert syndrome 20 Uncertain significance (Jul 26, 2022)2166575
16-75540045-A-G Meckel syndrome, type 11;Joubert syndrome 20 Benign/Likely benign (Jan 19, 2024)516202
16-75540046-A-G Meckel syndrome, type 11;Joubert syndrome 20 Uncertain significance (Sep 01, 2022)1488753
16-75540047-T-C Joubert syndrome 20;Meckel syndrome, type 11 Uncertain significance (Jul 06, 2022)1435796
16-75540054-C-T not specified • Joubert syndrome 20;Meckel syndrome, type 11 Conflicting classifications of pathogenicity (Jan 31, 2024)212404

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TMEM231protein_codingprotein_codingENST00000568377 618170
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.14e-70.5481246110241246350.0000963
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.4112011851.080.00001022179
Missense in Polyphen6464.7230.98883824
Synonymous-0.6808981.21.100.00000506704
Loss of Function0.9331216.00.7480.00000105149

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001230.000123
Ashkenazi Jewish0.000.00
East Asian0.0001120.000111
Finnish0.0001390.000139
European (Non-Finnish)0.00007280.0000708
Middle Eastern0.0001120.000111
South Asian0.0002290.000229
Other0.0001660.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transmembrane component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Required for ciliogenesis and sonic hedgehog/SHH signaling (By similarity). {ECO:0000250}.;
Disease
DISEASE: Joubert syndrome 20 (JBTS20) [MIM:614970]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. {ECO:0000269|PubMed:23012439, ECO:0000269|PubMed:26477546}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Meckel syndrome 11 (MKS11) [MIM:615397]: A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly. {ECO:0000269|PubMed:23349226}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.139
ghis
0.399

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tmem231
Phenotype
limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype;

Gene ontology

Biological process
in utero embryonic development;vasculature development;smoothened signaling pathway;regulation of protein localization;embryonic digit morphogenesis;camera-type eye development;cilium assembly;neuroepithelial cell differentiation
Cellular component
integral component of membrane;ciliary transition zone;MKS complex;ciliary membrane
Molecular function
protein binding